• Adams KM, Nelson JL 2004 Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291: 1127-1131. *

• Alexander SI, Smith N, Hu M, Verran D, Shun A, Dorney S, Smith A, Webster B, Shaw PJ, Lammi A, Stormon MO 2008 Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N. Engl. J. Med. 358: 369-374. *

• Araujo MB, Leonardi LS, Boin IF, Leonardi MI, Magna LA, Donadi EA, Kraemer MH 2004 Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant. Proc. 36: 953-955. *

• Araújo MB, Leonardi LS, Leonardi MI, Boin IF, Magna LA, Donadi EA, Kraemer MH 2008 Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation. Transpl. Immunol. Sep 10 [Epub ahead of print].

• Arimoto K, Kadowaki N, Ishikawa T, Ichinohe T, Uchiyama T 2007 FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. Int. J. Hematol. 85: 154-162.

• Artlett CM 2002 Microchimerism in health and disease. Curr. Mol. Med. 2: 525-535.

• Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG 2003 HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum. 48: 2567-2572. *

• Averdam A, Kuhl H, Sontag M, Becker T, Hughes AL, Reinhardt R, Walter L 2007 Genomics and diversity of the common marmoset monkey NK complex. J. Immunol. 178: 7151-7161. *

• Badenhoop K 2004 Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15.

• Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P 2007 The liver: a special case in transplantation tolerance. Semin. Liver Dis. 27: 194-213.

• Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM 2004 No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients. Gastroenterology 127: 1381-1385. *

• Boniotto M, Berti I, Santon D, Ventura A, Crovella S 2006 Absence of maternal microchimerism in very early onset inflammatory bowel disease R1. J. Gastroenterol. Hepatol. 21: 1082-1084. *

• Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Orstavik KH, Hegedus L 2005 High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 90: 5949-5953. *

• Bustos ML, Frias S, Ramos S, Estrada A, Arreola JL, Mendoza F, Gaxiola M, Salcedo M, Pardo A, Selman M 2007 Local and circulating microchimerism is associated with hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 176: 90-95.

• Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F 2006 Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J. Gene Med. 8: 1281-1290.

• Charatcharoenwitthaya P, Lindor KD 2005 Current concepts in the pathogenesis of primary biliary cirrhosis. Ann. Hepatol. 4: 161-175. *

• Chen YG, Scheuplein F, Osborne MA, Tsaih SW, Chapman HD, Serreze DV 2008 The Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in non-obese diabetic (NOD) mice. Diabetes Sep 5 [Epub ahead of print].

• Chilton PM, Rezzoug F, Ratajczak MZ, Fugier-Vivier I, Ratajczak J, Kucia M, Huang Y, Tanner MK, Ildstad ST 2005 Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients. Blood 105: 2189-2197. *

• Chinnakotla S, Smith DM, Domiati-Saad R, Agura ED, Watkins DL, Netto G, Uemura T, Sanchez EQ, Levy MF, Klintmalm GB 2007 Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transpl. 13: 157-161. *

• Cho EH, Suh KS, Yang SH, Lee HW, Cho JY, Cho YB, Yi NJ, Lee KU 2007 Acute graft versus host disease following living donor liver transplantation: first Korean report. Hepatogastroenterology 54: 2120-2122.

• Cho SG, Min SY, Park MJ, Lee KW, Cho YG, Cho ML, Chang HS, Park SH, Lee JW, Min WS, Kim CC, Kim HY 2006 Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum. 54: 1878-1887. *

• Cina RA, Wikiel KJ, Lee PW, Cameron AM, Hettiarachy S, Rowland H, Goodrich J, Colby C, Spitzer TR, Neville DM Jr, Huang CA 2006 Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation 81: 1677-1685.

• Clavijo-Alvarez JA, Hamad GG, Taieb A, Lee WP 2007 Pharmacologic approaches to composite tissue allograft. J. Hand Surg. [Am.] 32: 104-118.

• Corpechot C, Barbu V, Chazouilleres O, Poupon R 2000 Fetal microchimerism in primary biliary cirrhosis. J. Hepatol. 33: 696-700. *

• Daguindau N, Decot V, Nzietchueng R, Ferrand C, Picard C, Latger-Cannard V, Gregoire MJ, Beri M, Salmon A, Stoltz JF, Bordigoni P, Bensoussan D 2008 Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up. Clin. Immunol. 128: 164-171. *

• Dan YY, Yeoh GC 2008 Liver stem cells: a scientific and clinical perspective. J. Gastroenterol. Hepatol. 23: 687-698. *

• Demirkiran A, Bosma BM, Kok A, Baan CC, Metselaar HJ, Ijzermans JN, Tilanus HW, Kwekkeboom J, van der Laan LJ 2007 Allosuppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation. J. Immunol. 178: 6066-6072. *

• Di Campli C, Gasbarrini G, Gasbarrini A 2003 Review article: a medicine based on cell transplantation - is there a future for treating liver diseases? Aliment. Pharmacol. Ther. 18: 473-480. *

• Drexler C, Wagner T 2006 Blood group chimerism. Curr. Opin. Hematol. 13: 484-489.

• Dunne JR, Lee TH, Burns C, Cardo LJ, Curry K, Busch MP 2008 Transfusion-associated microchimerism in combat casualties. J. Trauma 64: S92-S97.

• Durakovic N, Radojcic V, Skarica M, Bezak KB, Powell JD, Fuchs EJ, Luznik L 2007 Factors governing the activation of adoptively transferred donor T-cells infused after allogeneic bone marrow transplantation in the mouse. Blood 109: 4564-4574. *

• Endo Y, Negishi I, Ishikawa O 2002 Possible contribution of microchimerism to the pathogenesis of Sjogren's syndrome. Rheumatology (Oxford) 41: 490-495. *

• Fanning PA, Jonsson JR, Clouston AD, Edwards-Smith C, Balderson GA, Macdonald GA, Crawford DH, Kerlin P, Powell LW, Powell EE 2000 Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J. Hepatol. 33: 690-695. *

• Fevery S, Billiau AD, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, Landuyt W, Kasran A, Boon L, Sagaert X, De Wolf-Peeters C, Waer M, Vandenberghe P 2007 CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease. Leukemia 21: 1451-1459.

• Fleta Asin B, Gonzalvo Liarte MC, Cia Gomez P 2006 Chimerism: origin and medical implications. Rev. Clin. Esp. 206: 340-342.

• Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM 2005 Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and MHC-mismatched allogeneic bone marrow transplantation. Blood 105: 2991-2994. *

• Forman D, Tian C, Iacomini J 2005 Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy. Mol. Ther. 12: 353-359.

• Fornoni A, Lenz O, Striker LJ, Striker GE 2003 Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice. Diabetes 52: 2594-2602. *

• Gadi VK, Nelson JL 2007 Fetal microchimerism in women with breast cancer. Cancer Res. 67: 9035-9038. *

• Gaia S, Cappia S, Smedile A, Bacillo E, Gaia E, Gubetta L, Rizzetto M 2006 Epithelial microchimerism: consistent finding in human liver transplants. J. Gastroenterol. Hepatol. 21: 1801-1806. *

• Gallego F, Gelpi C 2004 The IL-12 role in donor cell engraftment in a murine model of semiallogenic GVH disease with signs of autoimmune disease. Autoimmunity 37: 155-170.

• Gill RM, Lee TH, Utter GH, Reed WF, Wen L, Chafets D, Busch MP 2008 The TNFalpha (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood 111: 3880-3883. *

• Gilliam AC 2008 Scleroderma. Curr. Dir. Autoimmun. 10: 258-279.

• Gleicher N, Barad DH 2007 Gender as risk factor for autoimmune diseases. J. Autoimmun. 28: 1-6. *

• Good RA 2000 Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases. World J. Surg. 24: 797-810. *

• Grauslund J, Wang P 2004 Microchimerism - a possible cause of autoimmune disease? Ugeskr. Laeger. 166: 2882-2885.

• Grosskreutz C, Gudzowaty O, Shi P, Rodriguez-Laiz G, Malone A, Isola L 2008 Partial HLA matching and RH incompatibility resulting in graft versus host reaction and Evans syndrome after liver transplantation. Am. J. Hematol. 83: 599-601. *

• Guettier C, Sebagh M, Buard J, Feneux D, Ortin-Serrano M, Gigou M, Tricottet V, Reynes M, Samuel D, Feray C 2005 Male cell microchimerism in normal and diseased female livers from fetal life to adulthood. Hepatology 42: 35-43. *

• Guo ZY, He XS, Wu LW, Zhu XF, Ju WQ, Wang DP, You S, Ma Y, Wang GD, Huang JF 2008 Graft-verse-host disease after liver transplantation: a report of two cases and review of literature. World J. Gastroenterol. 14: 974-979. *

• Hackett CJ, Dickler HB 1999 Immunologic tolerance for immune system-mediated diseases. J. Allergy Clin. Immunol. 103: 362-370.

• Hajeer AH, Issa S, Alaskar A, Abdullah K, Awad M, Tbakhi A, Alabdulkareem A 2005 Neutrophils and lymphoid chimerism after adult living-related liver transplantation from a homozygous donor. Transplant. Proc. 37: 4386-4388. *

• Hakim F, Fowler DH, Shearer GM, Gress RE 2001 Animal models of acute and chronic graft-versus-host disease. Curr. Protoc. Immunol. Chapter 4: Unit 4.3.

• Hayashida M, Nishimoto Y, Matsuura T, Takahashi Y, Kohashi K, Souzaki R, Taguchi T 2007 The evidence of maternal microchimerism in biliary atresia using fluorescent in situ hybridization. J. Pediatr. Surg. 42: 2097-2101.

• Hosaka N, Ryu T, Miyake T, Cui W, Nishida T, Takaki T, Inaba M, Ikehara S 2007 Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation. Clin. Exp. Immunol. 147: 555-563. *

• Hovinga IC, Koopmans M, Baelde HJ, Wal AM, Sijpkens YW, Heer ED, Bruijn JA, Bajema IM 2006 Chimerism occurs twice as often in lupus nephritis as in normal kidneys. Arthritis Rheum. 54: 2944-2950. *

• Ichinohe T, Teshima T, Matsuoka KI, Maruya E, Saji H 2005 Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr. Opin. Immunol. 17: 546-552.

• Ikehara S 2008 A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. J. Autoimmun. 30: 108-115.

• Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F, Perego F, Bignotto M, Simoni G, Podda M 2000 Blood fetal microchimerism in primary biliary cirrhosis. Clin. Exp. Immunol. 122: 418-422. *

• Invernizzi P, Miozzo M, Oertelt-Prigione S, Meroni PL, Persani L, Selmi C, Battezzati PM, Zuin M, Lucchi S, Marasini B, Zeni S, Watnik M, Tabano S, Maitz S, Pasini S, Gershwin ME, Podda M 2007 X monosomy in female systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1110: 84-91.

• Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, Watnik M, Grati FR, Simoni G, Gershwin ME, Podda M 2005 X chromosome monosomy: a common mechanism for autoimmune diseases. J. Immunol. 175: 575-578. *

• Jager MD, Liu JY, Timrott KF, Popp FC, Stoeltzing O, Lang SA, Piso P, Geissler EK, Schlitt HJ, Dahlke MH 2007 Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats. Exp. Hematol. 35: 164-170. *

• Jansen AG, Vossen JM, Roelen DL, ten Cate R, Bredius GM 2005 The possible role of microchimerism in the aetiology of autoimmune diseases. Ned. Tijdschr. Geneeskd. 149: 1556-1560.

• Joffre O, Santolaria T, Calise D, Saati TA, Hudrisier D, Romagnoli P, van Meerwijk JP 2008 Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14: 88-92. *

• Johnson RW, Tew MB, Arnett FC 2002 The genetics of systemic sclerosis. Curr. Rheumatol. Rep. 4: 99-10.

• Jones DE 2000 Fetal microchimerism: an aetiological factor in primary biliary cirrhosis? J. Hepatol. 33: 834-837. *

• Jones DEJ 2003 Is microchimaerism an etiological factor of PBC? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 21-22. October 15-16. *

• Jonsson JR, Gu W, Vanags DM, Bishop GA, McCaughan GW, Fawcett J, Lynch SV, Balderson GA, Powell EE, Clouston AD 2004 Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transpl. 10: 397-403. *

• Julia M, Mascaro JM Jr, Guilabert A, Navarra E, Ferrando J, Herrero C 2008 Sclerodermiform linear lupus erythematosus: a distinct entity or coexistence of two autoimmune diseases? J. Am. Acad. Dermatol. 58: 665-667.

• Kadry Z, Mullhaupt B, Renner EL, Bauerfeind P, Schanz U, Pestalozzi BC, Studer G, Zinkernagel R, Clavien PA 2003 Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma. Transplantation 76: 1003-1006.

• Kanduc D, Stufano A, Lucchese G, Kusalik A 2008 Massive peptide sharing between viral and human proteomes. Peptides Jun 5 [Epub ahead of print]. *

• Kaplan MM, Bianchi DW 2004 Primary biliary cirrhosis: for want of an X chromosome? Lancet 363: 505-506. *

• Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH 2008 HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358: 353-361. *

• Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, Mayes MD, Champlin RE 2004 Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J. Rheumatol. 31: 2513-2516.

• Khosrotehrani K, Leduc M, Bachy V, Nguyen Huu S, Oster M, Abbas A, Uzan S, Aractingi S 2008 Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J. Immunol. 180: 889-897.

• Kikuta A, Ito M, Mochizuki K, Akaihata M, Nemoto K, Sano H, Ohto H 2006 Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction. Bone Marrow Transplant. 38: 665-669.

• Kim DH, Jung HD, Kwack DH, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS, Lee KB, Shin IH 2006 Predicting outcomes of HLA-identical allogeneic stem cell transplants from variable number of tandem repeat disparity between donors and recipients. Haematologica 91: 71-77. *

• Klintschar M, Immel UD, Kehlen A, Schwaiger P, Mustafa T, Mannweiler S, Regauer S, Kleiber M, Hoang-Vu C 2006 Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur. J. Endocrinol. 154: 237-241. *

• Koopmans M, Kremer Hovinga IC, Baelde HJ, Harvey MS, de Heer E, Bruijn JA, Bajema IM 2008 Chimerism occurs in thyroid, lung, skin and lymph nodes of women with sons. J. Reprod. Immunol. 78: 68-75.

• Kremer Hovinga IC, Koopmans M, Baelde HJ, de Heer E, Bruijn JA, Bajema IM 2007 Tissue chimerism in systemic lupus erythematosus is related to injury. Ann. Rheum. Dis. 66: 1568-1573.

• Kremer Hovinga IC, Koopmans M, de Heer E, Bruijn JA, Bajema IM 2007 Chimerism in systemic lupus erythematosus - three hypotheses. Rheumatology (Oxford) 46: 200-208. *

• Kumar L 2007 Haematopoietic stem cell transplantation: current status. Natl. Med. J. India 20: 128-137.

• Lambert N, Nelson JL 2003 Microchimerism in autoimmune disease: more questions than answers? Autoimmun. Rev. 2: 133-139.

• Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, Nelson JL 2000 Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164: 5545-5548. *

• Lambert NC, Pang JM, Erickson TD, Stevens AM, Yan Z, Furst DE, Nelson JL 2005 Male microchimerism in women with systemic sclerosis and healthy women who never gave birth to a son. Ann. Rheum. Dis. 64: 845-848. *

• Lambert NC, Stevens AM, Tylee TS, Erickson TD, Furst DE, Nelson JL 2001 From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann. N. Y. Acad. Sci. 945: 164-171.

• Lapaire O, Hosli I, Zanetti-Daellenbach R, Huang D, Jaeggi C, Gatfield-Mergenthaler S, Hahn S, Holzgreve W 2007 Impact of fetal-maternal microchimerism on women's health - a review. J. Matern. Fetal Neonatal Med. 20: 1-5.

• Leguern C 2007 Tolerogenic property of MHC class I and class II molecules: lessons from a gene therapy approach. Front. Biosci. 12: 3133-3139.

• Lessard MD, Alley TL, Proctor JL, Galvin N, Vogler CA, Soper BW 2006 Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation. Clin. Immunol. 119: 166-179. *

• Li JM, Gorechlad J, Larsen CP, Waller EK 2006 Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 12: 1239-1249.

• Li N, Zhao D, Kirschbaum M, Zhang C, Lin CL, Todorov I, Kandeel F, Forman S, Zeng D 2008 HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen. Proc. Natl. Acad. Sci. U.S.A. 105: 4796-4801. *

• Li Z, Benghiat FS, Kubjak C, Schuind F, Goldman M, Le Moine A 2007 Donor T-cell development in host thymus after heterotopic limb transplantation in mice. Transplantation 83: 815-818.

• Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M 2008 Is autoimmunity a matter of sex? Autoimmun. Rev. 7: 626-630.

• Lopez-Cubero SO, Sullivan KM, McDonald GB 1998 Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 114: 433-440. *

• Magliocca JF, Held IK, Odorico JS 2006 Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev. 15: 707-717.

• Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, Nelson JL 1999 Microchimerism of maternal origin persists into adult life. J. Clin. Invest. 104: 41-47. *

• Marmont AM 1998 Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 83: 733-743. *

• Marmont AM 2008 Will hematopoietic stem cell transplantation cure human autoimmune diseases? J. Autoimmun. 30: 145-150.

• Marmont AM, Gualandi F, Occhini D, Morandi F, Ferretti E, Pezzolo A, Strada P, Ravetti JL, Pistoia V, Falanga A, Bacigalupo A 2006 Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity 39: 505-511.

• Mellouli F, Torjmen L, Ksouri H, Abdelkefi A, Ladab S, Barbouche R, Othman TB, Hassen AB, Bejaoui M 2007 Bone marrow transplantation without conditioning regimen in Omenn syndrome: a case report. Pediatr. Transplant. 11: 922-926.

• Mikhail MA, M'hamdi H, Welsh J, Levicar N, Marley SB, Nicholls JP, Habib NA, Louis LS, Fisk NM, Gordon MY 2008 High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum. Reprod. 23: 928-933.

• Molleston JP, Alevy YG, SivaSai KS, Mohanakumar T, Howard TK 1996 Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. Transplantation 61: 656-657.

• Nadashkevich ON 2001 Autoimmune theory of pathogenesis of systemic scleroderma. Lik. Sprava. 2001: 15-17.

• Nagler A, Ilan Y, Amiel A, Eid A, Tur-Kaspa R 1994 Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization. Transplantation 57: 1458-1461.

• Nelson JL 2002 Microchimerism and human autoimmune diseases. Lupus 11: 651-654.

• Nelson JL 2002 Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol. Med. 8: 109-113. *

• Nelson JL 2001 HLA relationships of pregnancy, microchimerism and autoimmune disease. J. Reprod. Immunol. 52: 77-84.

• Nelson JL 1999 Microchimerism: implications for autoimmune disease. Lupus 8: 370-374.

• Nelson JL 1998 Microchimerism and the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 10: 564-571.

• Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, Erickson TD, Yan Z, Mullarkey ME, Boespflug ND, Bingley PJ, Gale EA 2007 Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc. Natl. Acad. Sci. U.S.A. 104: 1637-1642. *

• Neuhaus P 2003 Organ shortage. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 112-113. October 17 - 19. *

• Nikbin B, Bonab MM, Talebian F 2007 Microchimerism and stem cell transplantation in multiple sclerosis. Int. Rev. Neurobiol. 79C: 173-202.

• Nomura K, Sumida Y, Yoh T, Morita A, Matsumoto Y, Taji S, Yoshida N, Minami M, Itoh Y, Horiike S, Kataoka K, Taniwaki M, Okanoue T 2004 Lack of evidence for leukocyte maternal microchimerism in primary biliary cirrhosis. World J. Gastroenterol. 10: 2415-2416. *

• O'Donoghue K, Chan J, De La Fuente J, Kennea N, Sandison A, Anderson JR, Roberts PI, Fisk PN 2004 Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 364: 179-182. *

• O'Reilly RJ, Doubrovina E, Trivedi D, Hasan A, Kollen W, Koehne G 2007 Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunol. Res. 38: 237-250.

• Ostensen M, Villiger PM 2007 The remission of rheumatoid arthritis during pregnancy. Semin. Immunopathol. 29: 185-191.

• Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, Birlik AM, Calguneri M, Ozcelik T 2005 Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 52: 1564-1570. *

• Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E, Slatter MA, Le Deist F, Blanche S, Veys P, Fasth A, Bredius R, Sedlacek P, Wulffraat N, Ortega J, Heilmann C, O'Meara A, Wachowiak J, Kalwak K, Matthes-Martin S, et al 2008 Long-term outcome following hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and the European Group for Blood and Marrow Transplantation. Blood 111: 439-445. *

• Prummel MF, Strieder T, Wiersinga WM 2004 The environment and autoimmune thyroid diseases. Eur. J. Endocrinol. 150: 605-618. *

• Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Gungor T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I 2008 First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics 122: e778-e782. *

• Renne C, Ramos Lopez E, Steimle-Grauer SA, Ziolkowski P, Pani MA, Luther C, Holzer K, Encke A, Wahl RA, Bechstein WO, Usadel KH, Hansmann ML, Badenhoop K 2004 Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J. Clin. Endocrinol. Metab. 89: 5810-5814. *

• Rezzoug F, Huang Y, Tanner MK, Wysoczynski M, Schanie CL, Chilton PM, Ratajczak MZ, Fugier-Vivier IJ, Ildstad ST 2008 TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J. Immunol. 180: 49-57.

• Sakai M, Ohashi K, Ohta K, Yamashita T, Akiyama H, Kisida S, Kamata N, Sakamaki H 2006 Immune-mediated myelopathy following allogeneic stem cell transplantation. Int. J. Hematol. 84: 272-275.

• Sarkar K, Miller FW 2004 Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun. Rev. 3: 454-463.

• Sato T, Kobayashi R, Toita N, Kaneda M, Hatano N, Iguchi A, Kawamura N, Ariga T 2007 Stem cell transplantation in primary immunodeficiency disease patients. Pediatr. Int. 49: 795-800.

• Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S 2008 Tolerance and chimerism after renal and hematopoietic-cell transplantation. N. Engl. J. Med. 358: 362-368. *

• Schoniger-Hekele M, Muller C, Ackermann J, Drach J, Wrba F, Penner E, Ferenci P 2002 Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis. Dig. Dis. Sci. 47: 1909-1914. *

• Selmi C, Invernizzi P, Gershwin ME 2006 The X chromosome and systemic sclerosis. Curr. Opin. Rheumatol. 18: 601-605.

• Selva O'Callaghan A, Balada Prades E, Castells Fuste L, Vargas Blasco V, Solans Laque R, Vilardell Tarres M 2002 Fetal microchimerism in patients with primary biliary cirrhosis. Med. Clin. (Barc.) 119: 770-772.

• Shaw EA, Stevens AM 2008 Are pediatric autoimmune diseases primarily genetic diseases? Curr. Opin. Rheumatol. 20: 589-594.

• Sheil AG 1996 The new age of liver transplantation. Aust. N.Z. J. Surg. 66: 698-706.

• Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A 2006 Role of thymus in operational tolerance induction in limb allograft transplant model. Transplantation 81: 1568-1576.

• Skretkowicz J, Skretkowicz-Szarmach K 2006 Genetics in systemic sclerosis. Pol. Merkuriusz. Lek. 20: 117-120.

• Slatter MA, Brigham K, Dickinson AM, Harvey HL, Barge D, Jackson A, Bown N, Flood TJ, Cant AJ, Abinun M, Gennery AR 2008 Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency. J. Allergy Clin. Immunol. 121: 361-367.

• Smith-Berdan S, Gille D, Weissman IL, Christensen JL 2007 Reversal of autoimmune disease in lupus-prone NZB/NZW mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood 110: 1370-1378. *

• Sobecks RM, Ball EJ, Askar M, Theil KS, Rybicki LA, Thomas D, Brown S, Kalaycio M, Andresen S, Pohlman B, Dean R, Sweetenham J, Macklis R, Bernhard L, Cherni K, Copelan E, Maciejewski JP, Bolwell BJ 2008 Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 41: 709-714.

• Starzl TE 2007 Acquired immunologic tolerance: with particular reference to transplantation. Immunol. Res. 38: 6-41.

• Starzl TE, Lakkis FG 2006 The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology 43: S151-S163. *

• Starzl TE, Murase N, Demetris A, Trucco M, Fung J 2000 The mystique of hepatic tolerogenicity. Semin. Liver Dis. 20: 497-510.

• Staykova ND 2007 Rheumatoid arthritis and thyroid abnormalities. Folia Med. (Plovdiv.) 49: 5-12.

• Stevens AM 2006 Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus 15: 820-826.

• Stevens AM 2007 Do maternal cells trigger or perpetuate autoimmune diseases in children? Pediatr. Rheumatol. Online J. 5: 9. *

• Stevens AM, Hermes HM, Lambert NC, Nelson JL, Meroni PL, Cimaz R 2005 Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford) 44: 187-191. *

• Stevens AM, Michael McDonnell W, Mullarkey ME, Pang JM, Leisenring W, Lee Nelson J 2004 Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab. Invest. 84: 1603-1609.

• Stevens AM, Tsao BP, Hahn BH, Guthrie K, Lambert NC, Porter AJ, Tylee TS, Nelson JL 2005 Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum. 52: 2768-2773. *

• Sun K, Li M, Konopleva M, Konoplev S, Stephens LC, Kornblau SM, Frolova O, Wilkins DE, Ma W, Welniak LA, Andreeff M, Murphy WJ 2007 The synthetic triterpenoid, CDDO, suppresses alloreactive T cell responses and teduces murine early acute graft-versus-host disease mortality. Biol. Blood Marrow Transplant. 13: 521-529.

• Suskind DL, Rosenthal P, Heyman MB, Kong D, Magrane G, Baxter-Lowe LA, Muench MO 2004 Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol. 4: 14. *

• Tanaka A, Lindor K, Ansari A, Gershwin ME 2000 Fetal microchimerisms in the mother: immunologic implications. Liver Transpl. 6: 138-143. *

• Tanaka A, Lindor K, Gish R, Batts K, Shiratori Y, Omata M, Nelson JL, Ansari A, Coppel R, Newsome M, Gershwin ME 1999 Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 30: 833-838. *

• Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, Kambe M, Marusawa H, Chiba T, Manabe T 2005 Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation. Liver Transpl. 11: 547-554. *

• Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, Watson CJ, Delriviere L, Alexander GJ, Jamieson NV, Bradley JA, Taylor CJ 2004 Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation 77: 441-446.

• Trucco M 2006 Is facilitating pancreatic beta cell regeneration a valid option for clinical therapy? Cell. Transplant. 15 Suppl. 1: S75-S84.

• Tsutsumi Y, Tanaka J, Miura T, Saitoh S, Yamada M, Yamato H, Ehira N, Kanamori H, Kawamura T, Obara S, Ogura N, Matsushima T, Maruya E, Asaka M, Imamura M, Saji H, Masauzi N 2004 Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant. 34: 267-269.

• Turco AE, Bambara LM 2004 Pregnancy, microchimerism and autoimmunity: an update. Lupus 13: 659-660.

• Turul Ozgur T, Turkkani Asal G, Cetinkaya D, Orhan D, Kilic SS, Usta Y, Ozen H, Tezcan I 2008 Hematopoietic stem cell transplantation in a CD3gamma-deficient infant with inflammatory bowel disease. Pediatr. Transplant. May 11 [Epub ahead of print].

• Uz E, Loubiere LS, Gadi VK, Ozbalkan Z, Stewart J, Nelson JL, Ozcelik T 2008 Skewed X-chromosome inactivation in scleroderma. Clin. Rev. Allergy Immunol. 34: 352-355.

• Vanikar AV, Modi PR, Patel RD, Kanodia KV, Shah VR, Trivedi VB, Trivedi HL 2007 Hematopoietic stem cell transplantation in autoimmune diseases: the Ahmedabad experience. Transplant. Proc. 39: 703-708. *

• Verda L, An Kim D, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK 2008 Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice. Stem Cells 26: 381-386.

• Vinzio S, Lioure B, Grunenberger F, Schlienger JL, Goichot B 2004 Auto-immune-like disease post-bone marrow transplantation. Rev. Med. Interne. 25: 514-523.

• Waldorf KM, Nelson JL 2008 Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol. Invest. 37: 631-644. *

• Weger W, Bauer M, Odell E, Pertl B, Cerroni L, Kerl H, Jakse N, Pertl C 2006 Role of microchimerism in the pathogenesis of oral lichen planus. Exp. Dermatol. 15: 125-129.

• Weng L, Dyson J, Dazzi F 2007 Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment. Proc. Natl. Acad. Sci. U.S.A. 104: 8415-8420. *

• Willer CJ, Herrera BM, Morrison KM, Sadovnick AD, Ebers GC; for the Canadian Collaborative Study on Genetic Susceptibility to Multiple Sclerosis 2006 Association between microchimerism and multiple sclerosis in Canadian twins. J. Neuroimmunol. 179: 145-151.

• Xie SS, Jin YZ, Li AL, Qin FH, Wang GM, Ma JB, Hao J, Gao X 2007 Studies on the induction of transplantation tolerance and immune reconstitution through combinated strategies. Beijing Da Xue Xue Bao 39: 547-549.

• Xu Y, Flies AS, Flies DB, Zhu G, Anand S, Flies SJ, Xu H, Anders RA, Hancock WW, Chen L, Tamada K 2007 Selective targeting of the LIGHT-HVEM co-stimulatory system for the treatment of graft-versus-host disease. Blood 109: 4097-4104. *

• Yunis EJ, Zuniga J, Romero V, Yunis EJ 2007 Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance. Immunol. Res. 38: 213-236.

• Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, Perales MA, Rizzuto G, Menet E, Pamer EG, Heller G, Zuniga-Pflucker JC, Alpdogan O, et al 2006 Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat. Med. 12: 1039-1047. *

Number of references = 166

www psc-literature.org